ENPEP and osteosarcoma: In summary, our GSH-scavenging nanoplatform can effectively deliver J4 and Apa into osteosarcoma stem-like/progenitor cells effectively, with implications for increasing the drug uptake in the tumor cells, optimizing the drug intracellular release time, and improving the synergistic effects on therapy-resistant osteosarcoma cells.